FlowLeap vs Solve Intelligence: Copilot or Workspace?
Disclosure: FlowLeap is our product. Every statement about Solve Intelligence below comes from Solve Intelligence's own website or the cited source, fetched on 14 September 2026, and is cited in this page's sources. Solve Intelligence is the most established company in this category and its depth is real: drafting with figure generation, chemical structures and biological sequences, prosecution with office action analysis and examiner statistics, plus invalidity, FTO and infringement detection, all in one platform.
TL;DR
Solve Intelligence is an enterprise platform. You book a demo, sign a custom contract, and your matters live in its hosted application with the model cost bundled in. FlowLeap is a practitioner's workspace: a published flat price, a trial that needs no card, matters kept as files on your own machine, and every patent tool available inside the agent harness you already run. The choice is less about features than about who the buyer is and where the work is stored.
What each one is
Solve Intelligence sells "AI for patents": application drafting, prosecution, claim charting, patent litigation, and portfolio management and analysis in one browser-based platform. It raised a $40M Series B in December 2025, taking total funding to $55M, and launched Charts for litigation-grade invalidity, freedom-to-operate, infringement and claim construction work at the same time. Its customers page claims 700+ IP teams across six continents, including 20% of Chambers IP law firms and 20% of AmLaw 100 firms.
FlowLeap is a desktop app for macOS and Windows built on a VS Code fork. The agent searches USPTO and EPO data, including WO publications through EPO OPS, plus scientific literature; it does not invent patent numbers or claim text, every cited document comes from a real search, and conclusions link back to the passages that support them. The unit of work is the matter, and the matter is a folder of files you own.
At a glance
| FlowLeap | Solve Intelligence | |
|---|---|---|
| Scope | Search, analysis, drafting, prosecution and analytics run by one agent | Drafting, prosecution, charts and litigation in one platform |
| Where the matter lives | Files on your own machine | Solve's hosted application on AWS, with a US or EU subprocessor choice |
| Pricing | Published: 39 a month or 199 a year | Not published. Custom pricing on request |
| Trial | 7 days, no credit card, no keys needed | Demo-led. A two-week trial is listed as a NAPP member benefit |
| Model cost | Your own provider key at provider prices, no markup | Included in the subscription. No bring-your-own-key option appears on the pages cited here |
| Agent-harness access | 32 tools in Claude Code, Cursor, Codex and other MCP clients, same plan | MCP connector for research and analysis; drafting, prosecution and charts stay in the platform |
| Data sources | EPO, USPTO, WO, literature, MPEP, EPC and EPO Guidelines | Legal databases and patent office connections |
| Security | No training on your inputs or outputs; three named hosted features; public per-feature data-handling page | SOC 2 Type II, ISO 27001, ISO 42001, GDPR and CCPA |
Where Solve Intelligence is strong
Adoption and credibility. Very few products in patent AI can point to 700+ IP teams and a named roster of ranked firms, and for a partner making a firm-wide decision that evidence carries weight. The company also reports eight-figure annual recurring revenue and profitability, which matters when you are betting a practice on a vendor surviving the next five years.
Enterprise readiness. SOC 2 Type II, ISO 27001 and ISO 42001, GDPR and CCPA support, a US or EU subprocessor choice, and a statement that customer data is not used to train its models or third-party foundation models: that is a security questionnaire already answered. Add advanced administrative and permission management tools and custom integrations, and you have a product built for procurement.
Drafting depth. Figure generation, chemical structures and biological sequences are in the product. If your bottleneck is the first draft of a chemistry or biotech application, that is a capability set FlowLeap does not match today. Solve also reports that customers see 50%+ efficiency and quality improvements.
Where FlowLeap differs
The price is on the page. One flat plan, 39 a month or 199 a year, with no credits and no usage metering. You can read it, budget it, and expense it without a call. Solve's route to a number is "Contact us for enterprise pricing".
The trial needs nothing from you. Seven days, no credit card, with free AI models on a daily limit and shared EPO and USPTO data on a daily allowance, so a first real matter runs without setting up a single key. Solve's public path is a demo, with a two-week trial listed as a member benefit through NAPP rather than on the site.
Your matter stays a file. The workspace is local: matters, drafts, figures and generated reports live on your own machine, and your inputs and outputs are not used to train models. Exactly three limited features run on FlowLeap's own model accounts, namely document OCR, the analyst narration on the patent-analytics pages, and the public PATSTAT Try Agent, and they are named in public rather than described as "some features".
Your model, your bill. After the trial you bring your own provider key and pay that provider directly, with no credits, no token markup and no second meter; the EPO and USPTO credentials are free and take a few minutes to obtain. With Solve, model usage is part of the subscription, and your spend is whatever the contract says.
Full workflows inside your harness. One account and plan covers the desktop workspace, the CLI and the MCP server. The MCP server is local and puts 32 patent tools into Claude Code, Cursor, Codex, opencode, Cline, Gemini CLI, Windsurf, Zed, Roo Code and Goose. Solve's MCP connector exposes research and analysis, including prior art and invalidity research, freedom to operate, infringement analysis and SEP mapping, while advanced drafting, prosecution, claim charting and portfolio analysis stay inside the Solve platform and a Solve subscription is still required. That is the structural difference: in FlowLeap the harness runs the work, not only the lookups.
Live sources, quoted in full. The CLI reaches 170 million publications across EPO and USPTO data, academic papers and non-patent literature, and hybrid search over the MPEP, the EPC and the EPO Guidelines. That is what lets an agent answer an office action against the examiner's actual cited art, or test a chart element by element under the all-elements rule, with the quoted passage in front of you rather than a paraphrase.
Pricing, side by side
FlowLeap publishes one number. Solve publishes none, so any figure you see for it is inference. The nearest thing to a public anchor is the NAPP member benefit, which offers "15% off an annual subscription (equivalent of up to ~$1400 in value)". Read literally, that discount implies an annual subscription near $9,300 per user, roughly $775 a month. Treat that as an estimate derived from a partner page, not a quoted price, and ask Solve directly. Note also that Solve said in July 2026 that its Patent Copilot is available to a solo practitioner or small firm just as it is to any firm, without saying what the terms are.
| FlowLeap | Solve Intelligence | |
|---|---|---|
| Published price | 39 a month, or 199 a year | Not published |
| Estimate from a partner page | Not applicable | About $9,300 per user per year, derived from the NAPP discount |
| Model usage | Your own key, provider prices, no markup | Bundled in the subscription |
| Free trial | 7 days, self-serve, no card | Two weeks, listed as a NAPP member benefit |
The honest comparison is not 39 against 775. It is 39 plus your own model spend against a contract price you have to ask for. The second is often the right buy for a department with a procurement process. It is rarely the right buy for one attorney with a matter due on Friday.
Who should choose which
| Choose Solve Intelligence if | Choose FlowLeap if |
|---|---|
| You are buying for a firm or department and need admin controls and a signed security package | You are the practitioner and the buyer, and you want to start this afternoon |
| Drafting throughput in chemistry or biotech is the bottleneck, including figures and sequences | Research, analysis, charting and EPO opposition work are the bottleneck, and you want the sources shown |
| Your matters can live in a vendor cloud | Your matters must stay as files you keep and can archive |
| Bundled AI usage inside one contract suits your finance team | You want your own key, your own bill, and no meter |
| Procurement expects a demo and a custom contract | You want to read the price before you talk to anyone |
Both products are testable in a week. Bring one real matter, or a closed one whose answer you already know, and run it through each: compare the claims you would file, the citations you can open, and the work you would be willing to sign.
Related comparisons: FlowLeap vs IPRally, FlowLeap vs Patlytics, FlowLeap vs DeepIP and FlowLeap vs Rowan Patents.